Citi raises Fisher & Paykel Healthcare price target to NZ$51
Citi lifted its price target for Fisher & Paykel Healthcare by 28% to NZ$51 per share.
Story updates
11:30:24 PM UTC
SquawkNews
Fisher & Paykel Healthcare gains a bull in Citi, which thinks it offers investors both growth and reliable delivery. Citi expects "sustainable double-digit earnings growth in the midterm and lower exposure to consumer dynamics" from the medical-device maker than other healthcare stocks across Austr…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.